Área de Endodoncia

Medicine & Life Sciences

1. Tooth 100%
2. Dental Pulp 94%
3. Mesenchymal Stem Cells 85%
4. Regenerative Endodontics 85%
5. Platelet-Rich Fibrin 60%
6. Gingival Crevicular Fluid 57%
7. Dental Pulp Cavity 52%
8. Stem Cells 47%
9. Pulpitis 45%
10. Periapical Periodontitis 37%
11. Endodontics 35%
12. Cross-Sectional Studies 33%
13. Periodontitis 32%
14. Pre-Eclampsia 32%
15. Sagittal Split Ramus Osteotomy 32%
16. Dentin 30%
17. Cell Proliferation 29%
18. Tooth Wear 29%
19. Chile 28%
20. Mandibular Nerve 26%
21. Biomarkers 26%
22. tricalcium silicate 25%
23. Extracellular Vesicles 25%
24. Lasers 24%
25. Regeneration 22%
26. Cone-Beam Computed Tomography 22%
27. Calcium Hydroxide 21%
28. Pregnancy 21%
29. placental alkaline phosphatase 21%
30. Cell- and Tissue-Based Therapy 20%
31. Randomized Controlled Trials 20%
32. Microbiota 19%
33. Dentinal Fluid 18%
34. Intercellular Signaling Peptides and Proteins 17%
35. Biocompatible Materials 17%
36. Case-Control Studies 17%
37. Fibrin 17%
38. In Vitro Techniques 17%
39. Blood Platelets 16%
40. Umbilical Cord 16%
41. Logistic Models 15%
42. Dental Sac 15%
43. Dental Pulp Capping 15%
44. Dental Models 15%
45. Treponema denticola 15%
46. Blood Grouping and Crossmatching 14%
47. Systematic Reviews 14%
48. Dental Papilla 14%
49. Matrix Metalloproteinase 8 14%
50. Third Molar 14%
51. Therapeutics 14%
52. Workflow 14%
53. Low-Level Light Therapy 14%
54. mineral trioxide aggregate 14%
55. Vertical Dimension 14%
56. Dentifrices 14%
57. Aggressive Periodontitis 14%
58. Ultrasonic Waves 13%
59. Academic Performance 13%
60. Bicuspid 13%
61. Toll-Like Receptor 2 12%
62. Dentistry 12%
63. Population 12%
64. Intrinsic Factor 12%
65. Porphyromonas gingivalis 12%
66. Membranes 12%
67. Human Genetics 12%
68. Phase II Clinical Trials 12%
69. Clinical Trials, Phase I 12%
70. Atorvastatin 12%
71. Controlled Clinical Trials 12%
72. Deglutition 12%
73. poly(lactide) 11%
74. Polymers 11%
75. Porosity 11%
76. Composite Resins 11%
77. Molecular Pathology 11%
78. Growth Differentiation Factor 2 11%
79. Gestational Diabetes 11%
80. Angiogenesis Inducing Agents 11%
81. DNA 11%
82. Septodont 11%
83. Cell Differentiation 11%
84. Pedigree 11%
85. Matrix Metalloproteinase 9 10%
86. Formaldehyde 10%
87. Tongue 10%
88. Sepharose 10%
89. varespladib methyl 10%
90. Debridement 10%
91. Cheek 10%
92. Regulatory T-Lymphocytes 9%
93. Mandible 9%
94. High-Throughput Nucleotide Sequencing 9%
95. Pregnant Women 9%
96. Systemic Lupus Erythematosus 9%
97. Paraffin 9%
98. Suicide 9%
99. Growth 9%
100. Saints 8%